MEDIA & PRESS UPDATES
ISO CERTIFICATION ACHIEVED
June 13, 2022
At Lumendo, the highest quality standards are essential to us.
Our quality management system has been successfully audited. We are now official allowed to develop, manufacturer and distribute devices and materials for dental root canal treatments.
Click on the button below to see the complete certificate.
APPOINTMENT OF NEW MEMBERS TO THE LUMENDO BOARD OF DIRECTORS
February 16, 2022
Welcome to our new board members! We are happy to announce that Simone Übele-Näscher and Andreas Meldau have joined Lumendo in the quest for revolutionary endodontic treatments. Andreas Meldau was elected by the Lumendo board of directors as President of the board.
LUMENDO CLOSES 2.54 MCHF SEED FINANCING ROUND
January 7, 2022
We are very happy to announce the closing of our 2.54 MCHF seed financing round.
The financing round was led by Dominik Lysek, PhD, partner at US-based Revere Partners. Co-investors were Zürich Cantonal Bank and Business Angels Switzerland.
LUMENDO AG RECEIVES A DONGSHENG CUP AWARD
December 28, 2021
Creating new innovative products is our passion. Therefore, winning an award in the category "Most Innovative and Most Creative" of the "Dongsheng Cup" International Entrepreneurship Competition 2021 is all the more an honour for us.
NEW FINANCIAL ADVISOR
April 30, 2021
We are happy to welcome three new board advisors. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position in the endodontic market.
Today, we present our new financial advisor Dr. Patrick Griss:
After graduating with an M.Sc. in Microtechnology from EPF Lausanne (Switzerland), as well as a Ph.D. in Microsystem Technology from the KTH Royal Institute of Technology in Stockholm (Sweden), Dr. Patrick Griss is now an Executive Partner of Zühlke Ventures, a venture capital firm investing in medical device companies in Switzerland, Europe, America, and China.
TECH TOUR FUTURE 21 TOP PRESENTERS
March 26, 2021
Our CEO Andreas Schmocker was selected among the top presenters of Future 21 Tech Tour. Congratulations!
Tech Tour is a collaborative forum that brings together founders, developers, and industry leaders to share the partnerships, inspiration, and solutions needed to promote world-class innovation.
NEW ENTREPREUNARIAL ADVISOR
March 15, 2021
We are happy to welcome three new board advisors. We will present them during the next months. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position on the endodontic market.
Today, we present you Robert Frigg:
As an active medical device developer, Prof. Dr. h.c. mult. Robert Frigg has spent over 35 years in innovation management positions in the MedTech field. After almost 20 years working in different positions at the AO Foundation, including building up the AO Development Institute. From 1997 to 2003, he worked as VP of Innovation and New Concepts at Mathys Medical. From 2004 to 2012, he was worldwide responsible for technology and innovation as CTO at Synthes Inc., which was later sold to J&J for more than 20 billion USD. Since 2013, Robert Frigg setup and since 2019 owns 41medical, a MedTech company developing solutions for the human musculoskeletal system.
NEW GRANT FROM THE SWISS INNOVATION AGENCY
June 1, 2020
Our hand-santizer project "Disigel" is receiving further support from the Swiss Innovation Agency (Innosuisse). Together with the Swiss Federal Laboratories for Materials Science and Technology (EMPA) and the SPIEZ LABORATORY, we will further develop and test the safety and efficacy against Sars-CoV-2.
LUMENDO RECEIVES SUPPORT FROM THE GEBERT RÜF STIFTUNG
April 15, 2020
To help fighting the global Covid-19 pandemic, Lumendo received support from the Gebert Rüf Stiftung to develop a revolutionary, long-lasting hand sanitizer "Disigel". Find out more in the project description and the press release.
SELECTED AS VENTURE LEADER LIFE SCIENCE 2017
July 2017
Lumendo CEO and co-founder Andreas Schmocker is selected as a Venture Leader Life Science 2017. This enables him to travel to Boston as part of the Swiss National Startup Team to explore the US startup scene and the US dental and medical device market.
